Newest Topics

• Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and m by gavin
  3 hours, 30 minutes ago
• Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice by gavin
  1 day, 2 hours ago
• Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis. by gavin
  1 day, 2 hours ago
• Long-term outcomes of combined hepatocellular-cholangiocarcinoma after hepatecto by gavin
  2 days, 2 hours ago
• Mass-forming intrahepatic cholangiocarcinoma: Can diffusion-weighted imaging pre by gavin
  2 days, 2 hours ago
• Endoscopic radiofrequency biliary ablation treatment: a comprehensive review. by gavin
  2 days, 2 hours ago
• Immunotherapy and how do we know if it works plus “chemobrain?” by vasilikisimpson@yahoo.com
  2 days, 3 hours ago
• For Cholangiocarcinoma Patients, Mutations Matter by gavin
  4 days, 3 hours ago
• Endobiliary radiofrequency ablation for distal extrahepatic cholangiocarcinoma: by gavin
  4 days, 3 hours ago
• Discovering proteins for chemoprevention and chemotherapy by curcumin in liver f by gavin
  4 days, 3 hours ago
• False negative and false positive rates in common bile duct brushing cytology, a by gavin
  5 days, 3 hours ago
• Recurrent Cholangiocarcinoma in Pregnancy: A Case Report. by gavin
  5 days, 3 hours ago
• Successful response to the combination of immunotherapy and chemotherapy in chol by gavin
  6 days, 3 hours ago
• SOX9 expression decreases survival of patients with intrahepatic cholangiocarcin by gavin
  6 days, 3 hours ago
• Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intr by gavin
  6 days, 3 hours ago
• Klatskin tumors and “Klatskin-mimicking lesions”: our 22-year experience. by gavin
  6 days, 3 hours ago